SCHEMBL12411360

SCHEMBL12411360

[C-]#[N+]c1cc2c(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)c(F)c3)ccnc2cc1OCCCN1CCOCC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 8/20 0.60
EGFR P00533 6/20 0.60
KDR P35968 11/20 0.57
PDGFRA P16234 4/20 0.57
KIT P10721 3/20 0.57
AXL P30530 3/20 0.57
FGFR2 P21802 2/20 0.57
EPHX2 P34913 1/20 0.54
FLT1 P17948 3/20 0.51
FLT4 P35916 2/20 0.51
FLT3 P36888 2/20 0.50
RET P07949 2/20 0.49
IGF1R P08069 2/20 0.49
SRC P12931 2/20 0.49
MST1R Q04912 2/20 0.49
PLK4 O00444 1/20 0.49
STK25 O00506 1/20 0.49
CIT O14578 1/20 0.49
AURKA O14965 1/20 0.49
CHUK O15111 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12411421 0.96 KDR (0.57) METEGFRKDRPDGFRAKIT
SCHEMBL12411782 0.95 MET (0.60) METEGFRKDRPDGFRAKIT
SCHEMBL12411784 0.92 KDR (0.58) METEGFRKDREPHX2FLT1
SCHEMBL12411362 0.88 MET (0.67) METEGFRKDRPDGFRAKIT
SCHEMBL1896943 0.87 MET (0.60) METEGFRKDRPDGFRAKIT
SCHEMBL12411423 0.86 KDR (0.64) METEGFRKDRPDGFRAKIT
SCHEMBL12411322 0.85 KDR (0.61) METEGFRKDRPDGFRAKIT
SCHEMBL12411532 0.85 KDR (0.65) METEGFRKDRPDGFRAKIT
SCHEMBL5204265 0.85 KDR (0.73) METEGFRKDRPDGFRAKIT
SCHEMBL12412260 0.84 KDR (0.55) METEGFRKDRPDGFRAKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973160-B2 Nitrogen-containing aromatic derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-07-05 US disclosed
US-20100197911-A1 Nitrogen-Containing Aromatic Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-05 US disclosed
US-7612092-B2 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-11-03 US disclosed
US-7253286-B2 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI CO., LTD (JP) 2007-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197911-A1 Nitrogen-Containing Aromatic Derivatives GNG2, GCG, FRG1 MET 1810/4885EGFR 790/4885KDR 2687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.